# Cyngn Inc.: overview

CYN · Nasdaq · CIK 1874097 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cyn.md) · [Financials](/companies/cyn/financials.md) · [Filings](/companies/cyn/filings.md) · [Insiders](/companies/cyn/insiders.md)

Latest reported revenue: [$144.5k](/filings/0001437749-26-027718.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001437749-26-027718).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [47.6](/filings/0001213900-25-112611.md) | [306 d](/filings/0001213900-26-034900.md) | [47.2](/filings/0001213900-26-056821.md) | [33.7](/filings/0001437749-26-027718.md) | [70.0](/filings/0001213900-25-112611.md) | [68.1 d](/filings/0001213900-26-034900.md) | [105](/filings/0001213900-26-056821.md) | [144](/filings/0001437749-26-027718.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(11575.7%)](/filings/0001213900-25-112611.md) | [(1808.7%) d](/filings/0001213900-26-034900.md) | [(11060.0%)](/filings/0001213900-26-056821.md) | [(16313.4%)](/filings/0001437749-26-027718.md) | [(12028.9%)](/filings/0001213900-25-112611.md) | [(9621.1%) d](/filings/0001213900-26-034900.md) | [(6638.2%)](/filings/0001213900-26-056821.md) | [(4675.4%)](/filings/0001437749-26-027718.md) |
| Net margin | % | [(11405.9%)](/filings/0001213900-25-112611.md) | [(5261.2%) d](/filings/0001213900-26-034900.md) | [(8295.8%)](/filings/0001213900-26-056821.md) | [(16154.6%)](/filings/0001437749-26-027718.md) | [(12059.9%)](/filings/0001213900-25-112611.md) | [(8323.9%) d](/filings/0001213900-26-034900.md) | [(6203.1%)](/filings/0001213900-26-056821.md) | [(4398.8%)](/filings/0001437749-26-027718.md) |
| Diluted EPS | $ per share | [(408.30)](/filings/0001213900-25-112611.md) | not reported | [(3.40)](/filings/0001213900-26-056821.md) | [(2.70)](/filings/0001213900-25-073134.md) | [(1.20)](/filings/0001213900-25-112611.md) | not reported | [(0.59)](/filings/0001213900-26-056821.md) | not reported |
| Free cash flow | $k | [(5,487) d](/filings/0001213900-25-112611.md) | [(3,958) d](/filings/0001213900-26-034900.md) | [(6,692)](/filings/0001213900-26-056821.md) | [(6,432) d](/filings/0001437749-26-027718.md) | [(4,585) d](/filings/0001213900-25-112611.md) | [(7,099) d](/filings/0001213900-26-034900.md) | [(8,693)](/filings/0001213900-26-056821.md) | [(5,081) d](/filings/0001437749-26-027718.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [0.3](/filings/0001213900-24-020777.md) | [1.5](/filings/0001213900-25-110998.md) | [0.4](/filings/0001213900-26-034900.md) | [0.2](/filings/0001213900-26-034900.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | [(7404.9%)](/filings/0001213900-24-020777.md) | [(1567.6%)](/filings/0001213900-25-110998.md) | [(6201.0%)](/filings/0001213900-26-034900.md) | [(11731.1%)](/filings/0001213900-26-034900.md) |
| Net margin | % | not reported | [(7342.2%)](/filings/0001213900-24-020777.md) | [(1531.7%)](/filings/0001213900-25-110998.md) | [(9055.2%)](/filings/0001213900-26-034900.md) | [(10717.7%)](/filings/0001213900-26-034900.md) |
| Diluted EPS | $ per share | [(1.33)](/filings/0001213900-23-020719.md) | [(0.55)](/filings/0001213900-24-020777.md) | [(6528.92)](/filings/0001213900-25-110998.md) | [(2521.41)](/filings/0001213900-26-034900.md) | [(5.17)](/filings/0001213900-26-034900.md) |
| Free cash flow | $m | not reported | [(17.2)](/filings/0001213900-24-020777.md) | [(20.5)](/filings/0001213900-25-110998.md) | [(20.2)](/filings/0001213900-26-034900.md) | [(24.8)](/filings/0001213900-26-034900.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cyn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Empery Asset Management, LP](/funds/1469336.md) | 2026-06-30 | $1.3m | 927,059 |  | Reduced −30,725 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $438.0k | 315,119 |  | Added +245,466 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $171.9k | 123,638 |  | Added +82,513 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $133.9k | 96,300 |  | Added +72,600 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $104.1k | 74,896 |  | Added +40,117 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $37.7k | 27,137 |  | Added +3,891 |
| [TWO SIGMA SECURITIES, LLC](/funds/1450144.md) | 2026-06-30 | $20.0k | 14,356 |  | Reduced −31,396 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $16.2k | 11,624 |  | Reduced −5,724 |
| [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $14.6k | 10,471 |  | New +10,471 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $2.2k | 1,591 |  | Reduced −2,927 |

## Recent filings

[All 250 filings](/companies/cyn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 20:16 ET | [8-K](/filings/0001213900-26-109853.md) | 3.01 Delisting notice | 0001213900-26-109853 |
| 2026-09-21 | 20:15 ET | [DEF 14A](/filings/0001213900-26-101811.md) | Proxy statement, period 2026-11-03 | 0001213900-26-101811 |
| 2026-08-14 | 10:13 ET | [10-Q/A](/filings/0001213900-26-089408.md) | Quarterly report, amended, period 2026-06-30 | 0001213900-26-089408 |
| 2026-08-13 | 20:46 ET | [10-Q](/filings/0001437749-26-027718.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027718 |
| 2026-08-13 | 21:45 ET | [8-K](/filings/0001213900-26-088503.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088503 |
| 2026-07-30 | 20:51 ET | [8-K](/filings/0001213900-26-083386.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-083386 |
| 2026-05-21 | 21:20 ET | [8-K](/filings/0001213900-26-060162.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-060162 |
| 2026-05-14 | 21:14 ET | [10-Q](/filings/0001213900-26-056821.md) | Quarterly report, period 2026-03-31 | 0001213900-26-056821 |
| 2026-04-07 | 20:30 ET | [8-K](/filings/0001213900-26-041070.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-041070 |
| 2026-03-27 | 22:10 ET | [10-K](/filings/0001213900-26-034900.md) | Annual report, period 2025-12-31 | 0001213900-26-034900 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-034900.md), filed Mar 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/19a33c89-2ca7-40e7-907d-e4382339cf90)

## About the filer

- CIK: 1874097
- Tickers: CYN
- Exchange: Nasdaq
- SIC code: 7371 Services-Computer Programming Services
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.
